Beta Glucan Market Key Players Analysis, Company Profiles, Product Developments, Mergers, Strategic Collaborations, and Revenue Forecast Insights

Beta Glucan Market Companies Analysis

The Beta Glucan industry is expected to expand lucratively to an estimated value of US$ 1,147.71 Million by 2033, from US$ 638.75 Million in 2025. This expansion reflects a compound annual growth rate (CAGR) of 7.60% between 2025 and 2033.

The beta-glucan market is growing steadily, driven by increasing consumer awareness of health benefits associated with natural and functional ingredients. Beta-glucan, a polysaccharide derived from sources such as oats, barley, yeast, and mushrooms, is widely recognized for its cholesterol-lowering, immune-boosting, and heart health properties. Rising demand for dietary supplements, functional foods, and nutraceuticals has significantly boosted market growth. The ingredient is also gaining traction in pharmaceuticals and cosmetics due to its bioactive and antioxidant properties. Increasing adoption of clean-label and plant-based products further supports its market expansion. Additionally, growing interest in preventive healthcare and immunity-enhancing products after the pandemic has accelerated demand. Despite challenges like high extraction costs and limited consumer awareness in developing regions, the beta-glucan market continues to expand as a key player in the global health and wellness industry.

List of Leading Companies in the Beta Glucan Market

1. Ceapro Inc.

Establishment: 1997

Headquarters: Canada

Revenue: $7.1M in 2023

The biotechnology company Ceapro Inc. (Ceapro) is committed to producing and selling useful chemicals and extracts from oats and other renewable plant resources. The company's extracts are used in nutraceutical, cosmeceutical, and medical goods for humans, animals, and cosmetics. Ceapro's natural active ingredients include apenthamides, oat beta glucan, oat oil, oat peptides, oat powder, and lupin peptides. Ear cleanser, oat shampoo, and dermal complex/conditioner are further natural anti-aging skincare items and veterinary therapies. The company uses its own Pressurized Gas eXpanded (PGX) technique to extract the active chemicals. In addition to selling its products directly to consumers, it also uses distribution partners and subsidiaries. The company offers its products in the US, Canada, Europe, China, Japan, India, and other countries. Ceapro's main office is situated in Edmonton, Alberta, Canada.

2. Tate & Lyle PLC

Establishment: 1921

Headquarters: United Kingdom

Revenue: $2.0B in 2023

Tate & Lyle PLC (Tate & Lyle) is a provider of ingredient solutions for healthier foods and beverages. The company's product portfolio consists of sweeteners, texturants, and fiber enrichments. Animal feed, corn syrup, dextrose, glucose, starches, sweeteners, crystalline fructose, and sucrose are also supplied. Tate & Lyle sells its products under the trademarks Purefruit, Fructopure, Krystar, Tasteva, Amydex, Maltosweet, Star-Dri, Neto, Mira-Cap, Mira-Mist, Mira-Sperse, and Resistamyl. Drinks, dairy products, bread and snack items, soups, sauces, and dressings, confections, personal care products, medications, and animal feed are just a few of the industries that employ the company's products. Europe, the Middle East, Africa, Asia Pacific, and the Americas are all home to it. The headquarters of Tate & Lyle are located in London, UK.

3. Koninklijke DSM N.V.

Establishment: 1902

Headquarters: Switzerland

Revenue: $13.8B in 2023

The science-based company DSM-Firmenich AG (DSM-Firmenich) specializes in nutrition, health, and beauty. The company's primary activities include the development, manufacturing, and blending of essential nutrients, flavors, and fragrances. DSM-Firmenich produces a wide range of products, including specialty plastics, vitamins, carotenoids, fiber and resin solutions, and healthy lipids. The company's products and services are used by a number of industries, including food and beverage, pharmaceutical, biomedical materials, chemicals, cosmetics, and medical nutrition. The company operates in several regions, including the Americas, Europe, and Asia-Pacific. The DSM-Firmenich headquarters are situated in Kaiseraugst, Aargau, Switzerland.

4. Cargill Incorporated

Establishment: 1865

Headquarters: United States of America

Revenue: $ 160 B in 2023

Cargill Inc. is an agribusiness (Cargill). The company provides products and services in the fields of food, financial products, agriculture, industrial, and risk management. It markets, processes, and distributes meat, grains, oilseeds, sugar, and other food commodities in addition to cotton. The company also manufactures natural ingredients for the personal care industry, pet food, animal feed, and bio-industrial products. Cargill provides data asset solutions, marketing services, risk management services, logistics and transportation services, and technical support. Additionally, the company produces and markets biodiesel, fuel ethanol, starch, and starch sweeteners. Purina, Diamond V, Cargill, EWOS, Provimi, and Nutrena are just a few of the names under which it offers pet food and feed items. The company has operations in Europe, the Americas, the Middle East & Africa, and Asia Pacific. Cargill's headquarters are located in Minneapolis, Minnesota, in the United States.

5. Kerry Group Plc

Establishment: 1972

Headquarters: Ireland

Revenue: $7.5B in 2023

Kerry Group plc (Kerry Group) provides functional and nutritious solutions to the food, beverage, and pharmaceutical industries. The company's product line includes flavors, lipids, enzymes, fermented components, protein fractions, probiotics, bioactives, biopreservatives, metabolites, and other useful and nourishing substances. The company also sells chilled meals, meat, cereals, dairy flavor products, texturants, savory and sweet items, and taste modulation. Kerry Group markets its products under the DaVinci Gourmet, Big Train, Golden Dipt, and Island Oasis brands. The company uses a range of retailers, convenience stores, and internet marketplaces to offer food products. It has operations throughout Asia-Pacific, the Middle East, and the Americas. Kerry Group's headquarters are situated in Tralee, Kerry, Ireland.

SWOT Analysis of Beta Glucan Market

Givaudan SA Analysis

Global Leadership and Strong Innovation Capabilities

Givaudan SA's primary strength lies in its position as a global leader in flavors, fragrances, and active beauty ingredients, supported by a rich heritage and strong market presence. With operations in over 180 locations worldwide, the company serves a diverse client base across food, beverage, personal care, and household industries. Its robust R&D capabilities, combined with continuous investment in innovation and sustainability, enable the creation of cutting-edge, customized solutions that align with evolving consumer preferences. Givaudan's strategic acquisitions have further expanded its technological expertise and product portfolio, strengthening its competitive edge. The company's commitment to sustainability, quality, and sensory innovation helps it maintain strong relationships with global brands, solidifying its reputation as a trusted and forward-thinking industry leader.

Givaudan SA Opportunity Analysis

Expansion in Natural and Sustainable Ingredients

Givaudan SA has a significant opportunity to capitalize on the growing global demand for natural, plant-based, and sustainable ingredients. As consumers increasingly seek cleaner labels and environmentally responsible products, the company can expand its portfolio of eco-friendly and renewable formulations. Investing in biotechnology, green chemistry, and sustainable sourcing practices can help Givaudan lead the shift toward a circular and low-carbon economy. Additionally, strategic partnerships with local suppliers and startups can drive innovation and scalability in natural ingredients. The rising popularity of wellness-focused and ethical consumption trends provides a platform for Givaudan to strengthen its leadership in sustainable fragrance and flavor solutions, enhance customer loyalty, and create long-term value while supporting global environmental goals.

Euglena Co. Ltd. Strength Analysis

Pioneering Expertise in Microalgae Biotechnology

Euglena Co. Ltd.'s core strength lies in its pioneering expertise in microalgae biotechnology and sustainable bioinnovation. The company is globally recognized for harnessing Euglena microalgae-a unique organism rich in nutrients and bioactive compounds-to develop products across food, cosmetics, and biofuel sectors. Its integrated R&D framework allows continuous innovation, from cultivation to large-scale commercial applications. This technological advantage positions Euglena as a leader in sustainable biotechnology solutions that address nutrition, energy, and environmental challenges. The company's strong emphasis on research collaborations, eco-friendly production processes, and circular economy initiatives reinforces its brand credibility. By bridging biotechnology with sustainability, Euglena has successfully built a unique niche in the bio-based economy, combining scientific innovation with environmental responsibility.

Euglena Co. Ltd. Opportunity Analysis

Expansion into Sustainable Energy and Global Nutrition Markets

Euglena Co. Ltd. has immense growth opportunities in the global renewable energy and sustainable nutrition markets. With the rising demand for biofuels and eco-friendly energy alternatives, the company's advancements in algae-based biofuel technology can position it as a key contributor to low-carbon energy solutions. Additionally, increasing consumer focus on health and sustainable diets opens new avenues for its nutrient-rich algae-based food and supplement products. Expanding partnerships with governments and international organizations promoting green technologies can further accelerate its global presence. By scaling production and commercializing biofuel and functional food innovations, Euglena can play a pivotal role in addressing climate change and global food security challenges, while enhancing its competitiveness in the rapidly growing bioeconomy.

Merck KGaA Strength Analysis

Diversified Portfolio and Strong R&D Capabilities

Merck KGaA's primary strength lies in its diversified portfolio spanning life sciences, healthcare, and performance materials, which provides stability and resilience against market fluctuations. The company's strong research and development capabilities enable continuous innovation, particularly in biotechnology, oncology, and materials science. Its Life Science division, through brands like MilliporeSigma, plays a crucial role in supporting pharmaceutical and biotechnological advancements globally. Merck's commitment to scientific excellence and technological innovation fosters leadership in key areas such as drug discovery, specialty chemicals, and semiconductor solutions. Additionally, its global presence across more than 60 countries ensures a well-balanced revenue stream. This diversification, combined with a strong focus on sustainability and digitalization, positions Merck KGaA as a science-driven organization with a long-term competitive edge.

Merck KGaA Opportunity Analysis

Growth in Biotechnology and Personalized Medicine

Merck KGaA has significant opportunities to expand within biotechnology and personalized medicine, driven by advancements in genomics, diagnostics, and targeted therapies. As global healthcare increasingly shifts toward precision treatment, the company can leverage its expertise in biopharmaceutical development and molecular diagnostics to create innovative solutions tailored to individual patient needs. Furthermore, growing investments in biologics manufacturing and gene-editing technologies present new revenue streams. Collaborations with research institutions and biotech startups can accelerate innovation and strengthen Merck's leadership in life sciences. Additionally, increasing global demand for high-quality laboratory materials and bioscience tools enhances the company's growth potential. By capitalizing on these emerging trends, Merck KGaA can reinforce its role as a key enabler of next-generation healthcare and scientific innovation.

Recent Developments of Beta Glucan Market

• April 2024: The European Commission granted Kemin Industries, a major producer of ingredients worldwide, a novel food license for BetaVia Pure, which contains 95% beta 1,3 glucan.
• The U.S. Food and Drug Administration (FDA) approved Solabia-BioActor's Generally Recognized as Safe (GRAS) application for its women's health component Bonolive in March 2024.
• August 2023: In an FDA-registered lab, Immudyne Nutritional created PureMune, a beta-glucan component.

Beta Glucan Market & Forecast

• Historical Trends
• Forecast Analysis

Market Share Analysis - Beta Glucan

Company Analysis -Ceapro Inc.

Overview

• Company History and Mission
• Business Model and Operations
• Workforce

Key Persons

• Executive Leadership
• Operational Management
• Division Leaders
• Board Composition

Recent Development & Strategies

• Mergers & Acquisitions
• Partnerships
• Investments

Sustainability Analysis

• Renewable Energy Adoption
• Energy-Efficient Infrastructure
• Use of Sustainable Packaging Materials
• Water Usage and Conservation Strategies
• Waste Management and Circular Economy Initiatives

Product Analysis

• Product Profile
• Quality Standards
• Product Pipeline
• Product Benchmarking

Strategic Assessment: SWOT Analysis

• Strengths
• Weaknesses
• Opportunities
• Threats

Revenue Analysis

The above information will be available for all the following companies:

1. Tate & Lyle PLC

2. Koninklijke DSM N.V

3. Cargill Incorporated

4. Kerry Group Plc

5. Givaudan SA

6. Euglena Co. Ltd.

7. Merck KGaA

8. Lesaffre Group

9. Biotec Pharmacon ASA

10. Super Beta Glucan Inc.

11. Garuda International Inc.

12. Ohly GmbH

13. Angel Yeast Co. Ltd.

14. Lallemand Inc.

15. Alltech Life Sciences

16. Associated British Foods plc

17. Kemin Industries, Inc.

18. Biorigin Zilor Inc.

19. GlycaNova AS